Market closedNon-fractional

Capricor/CAPR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Capricor

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Ticker

CAPR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

102

Capricor Metrics

BasicAdvanced
$154M
Market cap
-
P/E ratio
-$0.86
EPS
3.97
Beta
-
Dividend rate
$154M
3.97
1.57
1.527
6.778
10.963
-31.65%
-197.34%
5.024
8.24
8.24
-4.084
389.30%
-26.63%
447.22%
-0.20%

What the Analysts think about Capricor

Analyst Ratings

Majority rating from 5 analysts.
Buy

Capricor Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-197.95% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$4.9M
-59.17%
Net income
-$9.7M
1,285.71%
Profit margin
-197.95%
3,295.37%

Capricor Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 173.53%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.29
-$0.25
-$0.02
-$0.31
-
Expected
-$0.35
-$0.29
-$0.09
-$0.11
-$0.36
Surprise
-17.14%
-13.79%
-77.78%
173.53%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Capricor stock?

Capricor (CAPR) has a market cap of $154M as of July 06, 2024.

What is the P/E ratio for Capricor stock?

The price to earnings (P/E) ratio for Capricor (CAPR) stock is 0 as of July 06, 2024.

Does Capricor stock pay dividends?

No, Capricor (CAPR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Capricor dividend payment date?

Capricor (CAPR) stock does not pay dividends to its shareholders.

What is the beta indicator for Capricor?

Capricor (CAPR) has a beta rating of 3.97. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Capricor stock

Buy or sell Capricor stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing